Cognitive & Neurotrophic · Research deep dive
Davunetide: the cited literature
Every study referenced in the Davunetide monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Davunetide is studied at 5 mg – 30 mg per administration, typically twice daily intranasally. The reference walkthrough below maps each citation to what it actually showed.
References covered
Davunetide in patients with progressive supranuclear palsy
Lancet Neurol., 2014
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Davunetide.